Search - tctmd.com

Displaying 401 - 420 of 485

Sort: Relevancy | Date

Presentation TCT 2015

USA Presents: Scaffold-Vessel Interactions: What the Interventionalist Should Know

Presenter: George D. Dangas, Eric Van Belle, Richard J. Rapoza

October 11, 2015

Presentation

Implantation of Everolimus-Eluting Bioresorbable Scaffolds in a Diabetic All-Comers Population

Presenter: Jens Wiebe

August 26, 2015

Presentation BRS 2015

BIORESORBABLE VASCULAR SCAFFOLDS A One-day Case-based Technique-oriented Course: A Case with Vessel and - or Lesion Tortuosity

Presenter: Antonio L. Bartorelli

February 10, 2015

Presentation

Beyond the Early Stages: Insights from the ASSURE Registry on Bioresorbable Vascular Scaffolds

Presenter: J. W?hrle

December 21, 2014

Presentation TCT 2014

Con: The Psychological Attraction Will Pass When the Data Emerges!

Presenter: Daniel I. Simon

September 16, 2014

Presentation TCT 2014

Pro: Within 10 Years, Most Coronary Intervention Will Use BRS!

Presenter: Stephan Achenbach

September 16, 2014

Presentation TCT 2014

TCT 612: Clinical Outcomes in Patients with Calcified Lesions Treated with Bioresorbable Vascular Scaffolds

Presenter: Dariusz Dudek, Pieter C. Smits, Vincent On-Hing Kwok, Vasileios Panoulas

September 16, 2014

Presentation TCT 2014

Status of DCB for PVD and Lessons Learned from the Recent FDA Panel

Presenter: Andrew Farb, Mitchell W. Krucoff, Aaron V. Kaplan, Juan F. Granada

September 16, 2014

Presentation TCT 2014

TCT 611: Multimodality Assessment 12 Months After Implantation of a Bioresorbable Scaffold for the Treatment of Culprit Lesions in Myocardial Infarction

Presenter: Dariusz Dudek, Pieter C. Smits, Vincent On-Hing Kwok, Ulrich Hink

September 16, 2014

Presentation TCT 2014

The Emphatic Case for OPCs NOW for New DES Approval in the United States!

Presenter: Andrew Farb, Mitchell W. Krucoff, Aaron V. Kaplan, Laura Mauri

September 16, 2014

Presentation TCT 2014

Imaging to Guide BRS: Nice to Have or Must Have?

Presenter: Dariusz Dudek, Pieter C. Smits, Vincent On-Hing Kwok, Evelyn S. Regar

September 16, 2014

Presentation TCT 2014

Device Approval Considerations (Preclinical and Clinical) for Bioresorbable Scaffolds: Update on FDA Regulatory Guidelines

Presenter: Andrew Farb, Mitchell W. Krucoff, Aaron V. Kaplan, Kenya Brothers

September 16, 2014

Presentation TCT 2014

Tips, Tricks, and Pearls to Optimize BRS Outcomes: From Lesion Preparation to Pharmacotherapy Considerations

Presenter: Dariusz Dudek, Pieter C. Smits, Vincent On-Hing Kwok, Jonathan M. Hill

September 16, 2014

Presentation TCT 2014

What Kind of Lesions are BRS Preferred in TODAY? TOMORROW?

Presenter: Dariusz Dudek, Pieter C. Smits, Vincent On-Hing Kwok, Azeem Latib

September 16, 2014

Presentation TCT 2014

BRS Under Development V Biolute BRS

Presenter: Alexandre Abizaid, Dean J. Kereiakes, Vasim Farooq, Dinesh Shah

September 16, 2014

Presentation TCT 2014

Will Bioresorbable Scaffolds Change How We Think About Left Main PCI?

Presenter: Andrejs Erglis, Nicholas J. Lembo, Hadley K. Wilson, Robert-Jan van Geuns

September 16, 2014

Presentation TCT 2014

BRS Under Development IV The Lepu BRS

Presenter: Alexandre Abizaid, Dean J. Kereiakes, Vasim Farooq, Yaling Han

September 16, 2014

Presentation TCT 2014

BRS Under Development III The XINSORB BRS

Presenter: Alexandre Abizaid, Dean J. Kereiakes, Vasim Farooq, Junbo Ge

September 16, 2014

Presentation TCT 2014

BRS Under Development II Meril Life Sciences

Presenter: Alexandre Abizaid, Dean J. Kereiakes, Vasim Farooq, Martin B. Leon

September 16, 2014

Presentation TCT 2014

BRS Under Development I The Manli Mirage BRS

Presenter: Alexandre Abizaid, Dean J. Kereiakes, Vasim Farooq, Teguh Santoso

September 16, 2014

Advertisement

USA Presents: Scaffold-Vessel Interactions: What the Interventionalist Should Know

Implantation of Everolimus-Eluting Bioresorbable Scaffolds in a Diabetic All-Comers Population

BIORESORBABLE VASCULAR SCAFFOLDS A One-day Case-based Technique-oriented Course: A Case with Vessel and - or Lesion Tortuosity

Beyond the Early Stages: Insights from the ASSURE Registry on Bioresorbable Vascular Scaffolds

Con: The Psychological Attraction Will Pass When the Data Emerges!

Pro: Within 10 Years, Most Coronary Intervention Will Use BRS!

TCT 612: Clinical Outcomes in Patients with Calcified Lesions Treated with Bioresorbable Vascular Scaffolds

Status of DCB for PVD and Lessons Learned from the Recent FDA Panel

TCT 611: Multimodality Assessment 12 Months After Implantation of a Bioresorbable Scaffold for the Treatment of Culprit Lesions in Myocardial Infarction

The Emphatic Case for OPCs NOW for New DES Approval in the United States!

Imaging to Guide BRS: Nice to Have or Must Have?

Device Approval Considerations (Preclinical and Clinical) for Bioresorbable Scaffolds: Update on FDA Regulatory Guidelines

Tips, Tricks, and Pearls to Optimize BRS Outcomes: From Lesion Preparation to Pharmacotherapy Considerations

What Kind of Lesions are BRS Preferred in TODAY? TOMORROW?

BRS Under Development V Biolute BRS

Will Bioresorbable Scaffolds Change How We Think About Left Main PCI?

BRS Under Development IV The Lepu BRS

BRS Under Development III The XINSORB BRS

BRS Under Development II Meril Life Sciences

BRS Under Development I The Manli Mirage BRS

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content